Sarcoidosis as an adverse effect of tumor necrosis factor inhibitors

Journal of Drugs in Dermatology

Volumn 11, Issue 5, 2012, Pages 609-612

  Cathcart, Shelley ^a   Sami, Naveed ^a   Elewski, Boni ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; DIPEPTIDYL CARBOXYPEPTIDASE; ETANERCEPT; INFLIXIMAB; METHOTREXATE; STEROID; TRIAMCINOLONE;

ADULT; ARTHRALGIA; BODY SURFACE; CASE REPORT; DERMATOLOGIST; DIET THERAPY; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ENZYME BLOOD LEVEL; EXERCISE; FATTY LIVER; FEMALE; GRANULOMA; GRANULOMATOSIS; HUMAN; HYPERTRANSAMINASEMIA; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER GRANULOMA; LYMPH NODE BIOPSY; MEDIASTINUM LYMPHADENOPATHY; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; RASH; RETROSPECTIVE STUDY; REVIEW; SARCOIDOSIS; SIDE EFFECT; SKIN BIOPSY; SKIN GRANULOMA; SUBCUTANEOUS NODULE; THORAX RADIOGRAPHY; TUBERCULIN TEST;

FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; MIDDLE AGED; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; RETROSPECTIVE STUDIES; SARCOIDOSIS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84860906495     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Massara A, Cavazzini L, La Corte R, Trotta F. Sarcoidosis appearing during anti-tumor necrosis factor alpha therapy: a new "class effect" paradoxical phenomenon. Two case reports and literature review. Semin Arthritis Rheum. 2010;39(4):313-319.
2. Almodóvar R, Izquierdo M, Zarco P, Javier Quirós F, Mazzucchelli R, Steen B. Pulmonary sarcoidosis in a patient with ankylosing spondylitis treated with infliximab. Clin Exp Rheumatol. 2007;25(1):99-101. (Pubitemid 46477494)
3. Daïen CI, Monnier A, Claudepierre P, Constantin A, Eschard JP, Houvenagel E, Samimi M, Pavy S, Pertuiset E, Toussirot E, Combe B, Morel J; Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology (Oxford). 2009;48(8):883-886.
4. Farah RE, Shay MD. Pulmonary sarcoidosis associated with etanercept therapy. Pharmacotherapy. 2007;27(10):1446-1448.
5. Farah R, Farah R, Makhoul N. Interferon-induced pulmonary sarcoidosis. Int J Clin Pharmacol Ther. 2005;43(9):441-443.
6. González-López MA, Blanco R, González-Vela MC, Fernández- Llaca H, Rodríguez-Valverde V. Development of sarcoidosis during etanercept therapy. Arthritis Rheum. 2006;55(5):817-820.
7. Hashkes PJ, Shajrawi I. Sarcoid-related uveitis occurring during etanercept therapy. Clin Exp Rheumatol. 2003;21(5):645-646. (Pubitemid 37236461)
8. Ishiguro T, Takayanagi N, Kurashima K, Matsushita A, Harasawa K, Yoneda K, Tsuchiya N, Miyahara Y, Yamaguchi S, Yano R, Tokunaga D, Saito H, Ubukata M, Yanagisawa T, Sugita Y, Kawabata Y. Development of sarcoidosis during etanercept therapy. Intern Med. 2008;47(11):1021-1025.
9. Josse S, Klemmer N, Moreno-Swirc S, Goëb V, Lequerré T, Vittecoq O. Infliximab induced skin and pulmonary sarcoidosis in a rheumatoid arthritis patient. Joint Bone Spine. 2009;76(6):718-719.
10. Kudrin A, Chilvers ER, Ginawi A, Hazleman BL, Griffiths MH, Thiru S, Ostor AJ. Sarcoid-like granulomatous disease following etanercept treatment for RA. J Rheumatol. 2007;34(3):648-649.
11. Metyas SK, Tadros RM, Arkfeld DG. Adalimumab-induced non-caseating granuloma in the bone marrow of a patient being treated for rheumatoid arthritis. Rheumatol Int. 2009;29(4):437-439.
12. O'Shea FD, Marras TK, Inman RD. Pulmonary sarcoidosis developing during infliximab therapy. Arthritis Rheum. 2006;55(6):978-981. (Pubitemid 44917474)
13. Peno-Green L, Lluberas G, Kingsley T, Brantley S. Lung injury linked to etanercept therapy. Chest. 2002;122(5):1858-1860. (Pubitemid 35366106)
14. Phillips K, Weinblatt M. Granulomatous lung disease occurring during etanercept treatment. Arthritis Rheum. 2005;53(4):618-20. (Pubitemid 41278929)
15. Skoie IM, Wildhagen K, Omdal R. Development of sarcoidosis following etanercept treatment: a report of three cases. Rheumatol Int. 2012;32(4):1049-1053.
16. Sturfelt G, Christensson B, Bynke G, Saxne T. Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab. J Rheumatol. 2007;34(11):2313-2314. (Pubitemid 350076897)
17. Toussirot E, Pertuiset E, Kantelip B, Wendling D. Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases. Clin Exp Rheumatol. 2008;26(3):471-475. (Pubitemid 352003220)
18. Vavricka SR, Wettstein T, Speich R, Gaspert A, Bachli EB. Pulmonary granulomas after tumour necrosis factor alpha antagonist therapy. Thorax. 2003;58(3):278-279. (Pubitemid 36308009)
19. Verschueren K, Van Essche E, Verschueren P, Taelman V, Westhovens R. Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients. Clin Rheumatol. 2007;26(11):1969-1971. Epub 2007 Mar 6.
20. Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet. 2003;361(9363):1111-1118. (Pubitemid 36369566)
21. Khanna D, Liebling MR, Louie JS. Etanercept ameliorates sarcoidosis arthritis and skin disease. J Rheumatol. 2003;30(8):1864-1867. (Pubitemid 36962468)
22. Sweiss NJ, Welsch MJ, Curran JJ, Ellman MH. Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis. Arthritis Rheum. 2005;53(5):788-791. (Pubitemid 41463847)
23. Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with infliximab. Chest. 2005;127(3):1064-1071. (Pubitemid 40775543)
24. Bachwich PR, Lynch JP 3rd, Larrick J, Spengler M, Kunkel SL. Tumor necrosis factor production by human sarcoid alveolar macrophages. Am J Pathol. 1986;125(3):421-425. (Pubitemid 17208825)
25. Crouser ED, Lozanski G, Fox CC, Hauswirth DW, Raveendran R, Julian MW. The CD4+ lymphopenic sarcoidosis phenotype is highly responsive to anti-tumor necrosis factor-{alpha} therapy. Chest. 2010;137(6):1432-1435.
26. Wijnen PA, Nelemans PJ, Verschakelen JA, Bekers O, Voorter CE, Drent M. The role of tumor necrosis factor alpha G-308A polymorphisms in the course of pulmonary sarcoidosis. Tissue Antigens. 2010;75(3):262-268. Epub 2010 Jan 11.